Breadcrumb

Vladimir A. Valera Romero M.D., Ph.D.

Vladimir A. Valera Romero M.D., Ph.D.

  • Center for Cancer Research
  • National Cancer Institute
Assistant Research Physician
Urologic Oncology Branch

RESEARCH SUMMARY

A surgeon-scientist by training, Dr. Valera specializes in providing compassionate and comprehensive genitourinary cancer care using a contemporary, multidisciplinary approach. He is particularly interested in the treatment of high-risk and locally-advanced prostate cancer and bladder cancer as well as rare urologic malignancies such as penile and testicular cancers.  Dr. Valera accomplishes his goal of providing comprehensive patient treatment by combining his extensive surgical experience in open, endoscopic and minimally invasive/robotic surgery with a basic science understanding of cancer at the molecular and cellular level. 

Areas of Expertise

Urologic Oncology
Penile Cancer
Testis Cancer

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.

Publications

Selected Key Publications

Comprehensive microRNA Profiling of Prostate Cancer

Walter BA, Valera VA, Pinto PA, Merino MJ.
Journal of Cancer. 4(5): 350-7, 2013. [ Journal Article ]

Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma

Valera VA, Walter BA, Linehan WM, Merino MJ.
Journal of Cancer. 2: 515-26, 2011. [ Journal Article ]

Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization

Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM.
PloS One. 5(12): e15793, 2010. [ Journal Article ]

Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2

Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM.
Proceedings of the National Academy of Sciences USA. 106(44): 18722-7, 2009. [ Journal Article ]

Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis

Valera VA, Walter BA, Yokoyama N, Koyama Y, Iiai T, Okamoto H, Hatakeyama K.
Annals of Surgical Oncology. 14(1): 34-40, 2007. [ Journal Article ]